CRL - Charles River Laboratories International, Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts13131414
Avg. Estimate2.632.3510.3612.09
Low estimate2.552.2210.0311.12
High estimate2.662.4710.7513
Year ago EPS2.772.6311.1210.36
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts11111414
Avg. Estimate1.05B999.44M4.13B4.48B
Low estimate1.04B981.28M4.08B4.33B
High estimate1.06B1.02B4.16B4.58B
Year ago sales973.13M989.16M3.98B4.13B
Sales growth (year/est)8.20%1.00%3.70%8.60%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS2.732.492.752.59
Actual EPS2.772.632.982.78
Difference0.040.140.230.19
Surprise %1.50%5.60%8.40%7.30%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate2.632.3510.3612.09
7 days ago2.632.3510.3612.09
30 days ago2.482.3910.2412.21
60 days ago2.482.3910.2212.22
90 days ago2.482.410.2412.29
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days7464
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCRLIndustrySector(s)S&P 500
Current qtr.-5.10%N/AN/AN/A
Next qtr.-10.60%N/AN/AN/A
Current year-6.80%N/AN/AN/A
Next year16.70%N/AN/AN/A
Next 5 years (per annum)8.13%N/AN/AN/A
Past 5 years (per annum)17.50%N/AN/AN/A